These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 1676858)
21. Cell-mediated versus humoral immunity in autoimmune diseases and their pharmacologic control with particular reference to type I diabetes mellitus. Boitard C; Bach JF Concepts Immunopathol; 1986; 3():193-224. PubMed ID: 3297326 [No Abstract] [Full Text] [Related]
22. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease. O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945 [TBL] [Abstract][Full Text] [Related]
23. Autoimmune syndrome after induction of neonatal tolerance to alloantigens. CD4+ T cells from the tolerant host activate autoreactive F1 B cells. Merino J; Schurmans S; Duchosal MA; Izui S; Lambert PH J Immunol; 1989 Oct; 143(7):2202-8. PubMed ID: 2570803 [TBL] [Abstract][Full Text] [Related]
24. T lymphocyte proliferative capacity and CD4+/CD8+ ratio in primiparous and pluriparous lactating cows. Mehrzad J; Zhao X J Dairy Res; 2008 Nov; 75(4):457-65. PubMed ID: 18701001 [TBL] [Abstract][Full Text] [Related]
25. [Autoimmunity. The path from physiologic immune reactions to autoimmune diseases]. Meyer zum Buschenfelde KH Med Monatsschr Pharm; 1989 Sep; 12(9):266-72. PubMed ID: 2477672 [No Abstract] [Full Text] [Related]
27. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines. Ben-Nun A; Cohen IR J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439 [No Abstract] [Full Text] [Related]
31. The use of synthetic antigens for the analysis of T cell recognition units and cellular interactions leading to immune reactions. Mozes E Ann Sclavo Collana Monogr; 1984; 1(2):103-18. PubMed ID: 6336257 [No Abstract] [Full Text] [Related]
34. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Horwitz DA; Zheng SG; Gray JD; Wang JH; Ohtsuka K; Yamagiwa S Semin Immunol; 2004 Apr; 16(2):135-43. PubMed ID: 15036237 [TBL] [Abstract][Full Text] [Related]
35. Smart weapons. Kraco K Minn Med; 2004 May; 87(5):28-32. PubMed ID: 15191065 [No Abstract] [Full Text] [Related]
37. Immunoregulation rather than immunosuppression for prevention and treatment of autoimmune disorders. Slavin S Transplant Proc; 1996 Dec; 28(6):3021-2. PubMed ID: 8962172 [No Abstract] [Full Text] [Related]
38. Functional roles for T cell CD40 in infection and autoimmune disease: the role of CD40 in lymphocyte homeostasis. Munroe ME Semin Immunol; 2009 Oct; 21(5):283-8. PubMed ID: 19539498 [TBL] [Abstract][Full Text] [Related]
39. Monocytosis and accelerated activation of lymphocytes in C1q-deficient autoimmune-prone mice. Trendelenburg M; Manderson AP; Fossati-Jimack L; Walport MJ; Botto M Immunology; 2004 Sep; 113(1):80-8. PubMed ID: 15312138 [TBL] [Abstract][Full Text] [Related]
40. Combined activation of innate and T cell immunity for recognizing immunomodulatory properties of therapeutic agents. Rose B; Herder C; Löffler H; Kolb H; Martin S J Leukoc Biol; 2004 Apr; 75(4):624-30. PubMed ID: 14704370 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]